Latest news with #ScottGottlieb
CNBC
14-05-2025
- Business
- CNBC
Dr. Scott Gottlieb on the impact of Pres. Trump's policies on Big Pharma and R&D
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of President Trump's tariff policy and executive order on the pharmaceutical industry, impact on R&D and new drug development, and more.
CNBC
12-05-2025
- Business
- CNBC
Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices
Scott Gottlieb, former FDA commissioner, joins CNBC's 'Squawk on the Street' to discuss how the White House may plan to cut drug prices.
Forbes
16-04-2025
- Business
- Forbes
Has More Chaos Stalled The Market Rally?
Roller coaster with clear blue sky The roller-coaster ride in the stock market has continued as Friday's seemingly positive reduction in the tariffs on electric goods was deemed temporary on Sunday before the markets opened on Monday. China's new policy on not accepting the delivery of Boeing jets was announced early Tuesday which is a further sign that the trade war is heating up not cooling down. The new rhetoric on pharma tariffs once again does not exhibit any real understanding of what new tariffs might mean. In Tuesday's CNBC interview with former CDA Commissioner with Dr. Scott Gottlieb, he revealed that 'just about 70% of the key ingredients, key chemicals substances that are used' to make widely used generic drugs all originate in China. The former FDA Commissioner is concerned that additional tariffs on some of these life-saving drugs, which have a small profit margin, will not continue to be produced because of new tariffs. After the market closed a regulatory filing by NVIDIA Corp. (NVDA) reported that the US 'required required licenses for exports to China of the company's H20 artificial intelligence chip. The chip giant said the move would result in $5.5 billion in charges to the company.' In early trading Wednesday NVDA is down 6.7%, trading at $104.71which is down $7.50 from Tuesday's close. There had been some signs over the past few days that the rebound was losing upside momentum. QQQ Many stocks opened very strong on Monday as there were hopes the Friday announcement of lower tariffs might be a sign of progress. The Invesco QQQ Trust (QQQ) had closed on Friday at $454.40 but opened Monday at $464.46 which was 2.2% higher. QQQ closed Monday at $457.48 which was well below the day's high of $465.05. On Tuesday the QQQ again traded above the 20-day EMA at $461.32 but closed at $457.99. There is chart support to watch at Friday's low of $441.33 with the monthly S1 pivot support at $446.74. The Nasdaq 100 A/D line has just rebounded back to its EMA as it closed just above it on Tuesday. If the QQQ A/D numbers are negative on Wednesday it will be consistent with a failing rally. There is support at the recent lows and then the uptrend, line c. The AD line needs to move above the downtrend, line b, to signal that the correction in QQQ is over. The relative performance (RS) is above its EMA but it needs to overcome the recent highs to indicate that QQQ is now leading the SPY. A move above the major RS resistance at line d is needed to confirm that QQQ is leading the SPY. NYSE Composite The loss of upside momentum was also evident on the more broadly-based NYSE Composite as it closed Tuesday on the day's lows as it failed to reach the 20-day EMA at 18,663. There is further chart resistance, line a, in the 18,818 area. The NYSE McClellan Oscillator rallied from the April 8th low to close Tuesday just above zero at +10.59. The downtrend at line b needs to be overcome to signal a further rally. The NYSE All Advance/Decline line has rallied from the recent lows but is still below the declining EMA and resistance at line d. The downtrend in the A/D line (line c) needs to be overcome to turn it positive. The S&P futures are down 41 points at 8:30 AM ETF which is an hour before the open. Of course, it is the close that will be more important. If the stock market declines sharply for a few days it will hopefully encourage a return to sanity before there are new ill-informed tariffs on the pharma industry.
Yahoo
01-04-2025
- Business
- Yahoo
Argus cuts Illumina target, sees buying opportunity
Argus lowered the firm's price target on Illumina (ILMN) to $100 from $170 and keeps a Buy rating on the shares. The stock has fallen significantly over the past several months amid geopolitical tensions, antitrust issues, and slowing product sales, the analyst tells investors in a research note. However, the firm believes Illumina 'appears to be turning the corner,' delivering multiple quarters of margin growth, launching new products and services, and providing 'strong' earnings guidance for 2025. The stock's 'discounted price' offers a buying opportunity, contends Argus. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on ILMN: Disclaimer & DisclosureReport an Issue Illumina price target lowered to $122 from $150 at Guggenheim Corvex's Keith Meister to join Illumina's board, WSJ reports Illumina elects Dr. Scott Gottlieb as Chair, Keith Meister to join board No change to Illumina story amid board changes, 'eventful' 24 hours, says BofA Activist Investors Seize More Control of Illumina Amid Weakness Sign in to access your portfolio
Yahoo
28-03-2025
- Business
- Yahoo
Why warm weather could drive egg prices up again
Egg prices have dropped a lot in the last month, down 40% from the end of February, according to the American Enterprise Institute. But it's a real shame that eggs don't stay fresh for a long, long time so folks can stock up, because some predict that prices will rise again as wild birds start circulating broadly in warm weather, potentially creating a surge in bird flu. That could create another egg-price crisis and leave consumers shell-shocked yet again. Newsweek reported that prices have been volatile. On March 3, they were at a historic high of $8.17 a dozen, 'attributed to tight supplies and seasonable demand.' The article takes its numbers from Trading Economics, which uses government data and showed the prices have fallen to $2.92. In early January, eggs were $5.81. They've slid up and down since. There's a very strong link between H5N1 avian influenza and the cost of eggs. Since the virus began circulating broadly in the U.S., 166 million egg-laying hens have been from infected farms. That's greatly reduced the number of eggs, which has in turn driven up prices. which is a project of the Annenberg Public Policy Center, has slightly different numbers but points to the same issues. Per the article, 'What is now the largest bird flu outbreak since 2015 has caused an egg shortage, as tens of millions of egg-producing hens have had to be killed to prevent further spread of the virus. As of March 20, more than 168 million birds had been affected in total, according to USDA data. Over 30 million birds from commercial egg layer flocks have been lost in 2025 alone." Writes AEI senior fellow Scott Gottlieb, 'Demand for eggs will likely remain strong, particularly with the Easter holiday drawing near. And our current respite from avian flu outbreaks may prove short-lived. The avian influenza strains now in circulation have persisted continuously among birds and mammals for nearly two years, and there's growing evidence that it could become a permanent feature of North America — part of a new normal to which the poultry industry must inevitably adjust for both the physical and economic health of Americans.' Bird flu is spread primarily by wild birds, which infect other animals, including those that eat wild birds. The virus has infected a number of different mammals, including a few humans in the U.S. who have come in close contact, primarily on dairy or poultry farms. Both dairy cows and poultry farms have experienced recent, serious outbreaks. A number of approaches have been suggested to deal with the egg price conundrum, which is definitely tied into the question about how to tackle bird flu. A week ago, Robert F. Kennedy Jr., who is now the country's top health official in his role over the Department of Health and Human Services, suggested that instead of killing infected birds and removing them, farmers 'should consider maybe the possibility of letting it run through the flock so that we can identify the birds and preserve the birds that are immune to it,' as reported by both The New York Times and Fox News. Others worry that it would decimate the egg industry as so many hens became infected and could no longer supply eggs. And since viruses tend to mutate, allowing bird flu to run unchecked could ramp up the risk that it will change in ways that make it easier to infect other species, including humans. Per the Times, each infection gives the virus a chance to become more virulent. So far, it doesn't easily spread among people. 'But if H5N1 were allowed to run through a flock of 5 million birds, 'that's literally 5 million chances for that virus to replicate or to mutate,'' Dr. Gail Hansen, former Kansas state veterinarian, told the Times. Critics also note that it's not known if there would be any hens that are naturally immune. And if so, they might not be immune to a subsequent mutation. Others, including Gottlieb, believe that strategies to vaccinate egg-laying hens could be explored, though there are potential downsides like 'technological feasibility of mass vaccinations and trade objections; however, they can be addressed by advancing vaccine innovations and increasing biosecurity,' as he put it. Newsweek notes that 'in February, the (U.S. Department of Agriculture) unveiled a $1 billion, five-point plan to tackle the price of eggs which included an 'additional $500 million for biosecurity measures, $400 million in financial relief for affected farmers, $100 million for vaccine research, action to reduce regulatory burdens and exploring temporary import options.'' President Donald Trump had called for importing eggs from other countries while U.S. prices are high, and this week, Newsweek reported the administration has reached an agreement to import eggs from Turkey and South Korea to help keep prices down. Easter, by the way, is likely to increase demand, which could also raise egg prices somewhat. As Newsweek reported, 'The USDA has predicted egg prices could soar more than 40% in 2025 and (Department of Agriculture Secretary Brooke) Rollins said the Easter season would increase egg demand, resulting in spiking prices.'
